Skip to main content
Fig. 10 | BMC Medicine

Fig. 10

From: Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials

Fig. 10

Potential molecular mechanism of probiotics in the treatment of autoimmune diseases (The mechanism is summarized from [11, 26, 27, 129, 136,137,138,139, 151,152,153,154,155,156,157,158]. AhR: aryl hydrocarbon receptor; CNS: central nervous system; FFARs: free fatty acid receptors; GLP1: glucagon-like protein-1; GPRs: G-binding protein receptors; H2: histamine receptor 2; PYY: peptide tyrosine tyrosine; SCFAs: short-chain fatty acids)

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us